| Literature DB >> 28934118 |
Phitsini Suvarnaphaet1, Suejit Pechprasarn2.
Abstract
The advantages conferred by the physical, optical and electrochemical properties of graphene-based nanomaterials have contributed to the current variety of ultrasensitive and selective biosensor devices. In this review, we present the points of view on the intrinsic properties of graphene and its surface engineering concerned with the transduction mechanisms in biosensing applications. We explain practical synthesis techniques along with prospective properties of the graphene-based materials, which include the pristine graphene and functionalized graphene (i.e., graphene oxide (GO), reduced graphene oxide (RGO) and graphene quantum dot (GQD). The biosensing mechanisms based on the utilization of the charge interactions with biomolecules and/or nanoparticle interactions and sensing platforms are also discussed, and the importance of surface functionalization in recent up-to-date biosensors for biological and medical applications.Entities:
Keywords: bioimaging; biosensor devices; electrochemical; field-effect transistor; functionalized graphene; graphene; instrumentation; surface plasmon resonance
Mesh:
Substances:
Year: 2017 PMID: 28934118 PMCID: PMC5677231 DOI: 10.3390/s17102161
Source DB: PubMed Journal: Sensors (Basel) ISSN: 1424-8220 Impact factor: 3.576
Figure 1Schematic illustration of a typical biosensor system.
Figure 2Structures of graphene-based materials show (a) the pristine graphene (pure-arranged carbon atoms) with sp2-hybridized carbon atoms, and the chemically modified graphene, including (b) graphene oxide (GO); (c) reduced graphene oxide (RGO) and (d) graphene quantum dot (GQD).
Figure 3Several techniques of graphene synthesis: (a) graphene sheet is left on top of a silicon oxide wafer exfoliated by scotch-tape technique, its electronic band structure, and the real monolayer and bilayer graphene (Reprinted with permission from [39]); (b) Large scale process of graphene growth using (chemical vapor deposition) CVD and the transferred graphene to poly(methyl methacrylate) (PMMA) (reprinted with permission from [40]); (c) Liquid exfoliation of graphene showing crystalline honeycomb pattern on the exfoliated layer (reprinted with permission from [41]); and (d) epitaxial graphene growth on a silicon carbide (SiC) by sublimation of Si atoms and the structural characteristic of the monolayer graphene (reprinted with permission from [42]).
Figure 4Schematic structure of chemical synthesis based on Lerf-Klinowski model.
Figure 5Schematic illustration and photoluminescent mechanism of carbon-based dots, including graphene quantum dot (GQD), carbon quantum dot (CQD), carbon nanodot (CND), compared to the quantum dots made of semiconductor (SQD).
Figure 6Schematic illustration of the graphene-based materials that can be immobilized with biomolecules as the receptor.
Current generation reports of graphene-based biosensors.
| Technique | Receptor System | Target Biomolecules | Limit of Detection | References |
|---|---|---|---|---|
| FRET 1 | Boron-doped GQDs 2/ATP 3 | Ce3+ ions in MCF-7 4 cells | 0.4 mM in 10 ± 5 cell/mL | [ |
| FRET | MWCNTs@GONRs 5 | dual tDNAs (P35s 6 and TNOS 7) | 0.35 nM for P35 s | [ |
| FRET | GQD-PEG-aptamer/MoS2 | EpCAM 8 | 450 pM | [ |
| GFET 9 | Graphene/Tris-HCl | Pb2+ | <37.5 ng/L | [ |
| GFET | Graphene/Anti-CEA 10 | CEA protein | <100 pg/mL | [ |
| GFET | Graphene/DNA | Pb2+ | 163.7 ng/L | [ |
| GFET | Graphene | DNA | 10 pM | [ |
| GO 11 FET | GO/pentacene | Artificial DNA | 0.1 pM | [ |
| GpO 12 FET | GpO/Cu or AgNPS | Glucose | 1 μM | [ |
| RGO 13 FET | Urease/PEI 14/RGO | Urea | 1 μM | [ |
| RGO FET | PtNPS | BNP 15 | 0.1 pM | [ |
| GSPR 16 | Biotin-SA 17/GO | DNA | - | [ |
| GLSPR 18 | Ni/graphene | 3-NT 19 | 0.13 pg/mL | [ |
| SPR | RGO | Rabbit IgG 20 | 0.3125 μg/L | [ |
| SPR | Au/GO–COOH | Anti-BSA 21 | 0.01 pg/mL | [ |
| SPR | Lysozyme in serum | 0.05 μg/mL | [ | |
| SPR | GO/(N-) PPLRINRHILTR(-C) 22 | HCG 23 | 0.065 nM | [ |
| Fiber optic SPR | Ag-MoS2-Graphene | DNA | 1 μM | [ |
| SPR | Graphene–MoS2 | ssDNA | - | [ |
| ECHEM 24 | AuNPS/GO | MCF-7 | 0.0375 μg/mL | [ |
| ECHEM | NH2-GS/Au@Pt/PDA-N-MWCNT 25 | AFP 26 | 0.1 pg/mL | [ |
| ECHEM | FAO 27/N-doped graphene/AuNPS/FTO | HbA1c 28 | 0.2 μg/mL | [ |
| ECHEM | Pd-Au@carbon dots | 1.82 × 10−17 M | [ | |
| ECHEM | Ni-MG-BDD 29 | Glucose | 0.24 μM | [ |
| ECHEM | AQ-labeled acpcPNA 30 G-PANI | HPV-DNA type 16 | 2.3 nM | [ |
| ECHEM | GO-ssDNA/Au | VEGF 32 | 0.05 ng/mL | [ |
| PLLA 31/GO-ssDNA/Au | PSA 33 | 1 ng/mL | ||
| ECHEM | MoS2-Graphene/L-cysteine | PTH 34 | 1 pg/mL | [ |
| ECHEM | MoS2/graphene | ctDNA 35 | 0.0001 pM | [ |
| ECHEM | AuNPS/MoS2/graphene/GCE 36 | DNA | 0.0022 pM | [ |
| ECHEM | Calix[4]arene phosphoryl/graphene electrode | Carbofuran | 1 μM | [ |
| ECHEM | Anti human | 1 μM | [ | |
| Electron transfer | MoS2/GO | Glucose in human serum | 65 nM | [ |
Notes: 1 FRET: fluorescence resonance energy transfer, 2 GQDs: graphene quantum dots, 3 ATP: adenosine triphosphate, 4 MCF-7: Michigan Cancer Foundation-7 (breast cancer cells),5 GONRs: graphene oxide nanoribbons, 6 P35s: promoter cauliflower mosaic virus 35 s, 7 TNOS: terminator nopaline synthase (from transgenic soybean), 8 EpCAM: epithelial cell adhesion molecule, 9 GFET: graphene field effect transistor, 10 CEA: carcinoembryonic antigen, 11 GO: graphene oxide, 12 GpO: graphite oxide, 13 RGO: reduced graphene oxide, 14 PEI: polyethylenimine, 15 BNP: brain natriuretic peptide (heart failure), 16 GSPR: graphene based surface plasmon resonance, 17 Biotin-SA: biotin-streptavidin, 18 GLSPR: graphene localized surface plasmon resonance, 19 3-NT: 3-nitro-l-tyrosine, 20 Rabbit immunoglobulin G, 21 BSA: bovine serum albumin protein, 22 (N-) PPLRINRHILTR(-C): (N-Pro-ProLeu-Arg-Ile-Asn-Arg-His-Ile-Leu-Thr-Arg-C), 23 HCG: human chorionic gonadotropin protein, 24 ECHEM: electrochemistry, 25 PDA-N-MWCNT: poly-dopamine functionalized N-doped multi-walled carbon nanotube, 26 AFP: Alpha fetoprotein, 27 FAO: fructosyl amino-acid oxidase, 28 HbA1c: Glycatedhemoglobin, 29 Ni-MG-BDD: nickel-microcrystalline graphite-boron doped diamond, 30 acpcPNA: anthraquinone-labeled pyrrolidinyl peptide nucleic acid, 31 VEGF : vascular endothelial growth factor, 32 PLLA: poly-L-lactide, 33 PSA: prostate-specific antigen, 34 PTH: parathyroid hormone, 35 ctDNA: circulating tumor DNA, 36 GCE: carbon glassy electrode.
Figure 7Schematic illustrations of graphene-based biosensors: (a) Pb2+ in blood biosensor based on GFET (reprinted with permission from [49]); (b) Pb2+ biosensor based on graphene/DNA (reprinted with permission from [109]); (c) CEA protein biosensor based on graphene/anti-CEA (reprinted with permission from [108]); (d) real-time binding kinetics and affinity of DNA hybridization based on GFET (reprinted with permission from [50]); (e) paper-based biosensor for human papillomavirus (HPV) detection (reprinted with permission from [127]); and (f) a lipid-based modified graphene electrochemical biosensor (reprinted with permission from [135]).
Figure 8Schematic illustration of functionalized graphene-based biosensors: (a) a glucose detection based on GO FET (reprinted with permission from [111]); (b) DNA detection based on printing GO/pentacene FET (reprinted with permission from [110]); (c) urea platform biosensor based on Urease/PEI/RGO FET (reprinted with permission from [112]); (d) Heart failure detection based on Pt NPS/RGO FET (reprinted with permission from [113]); (e) Biotin-SA/GO SPR chip (reprinted with permission from [114]); (f) BSA biosensor based on GO-COOH enhanced SPR (reprinted with permission from [117]); (g) rabbit IgG detection based on RGO SPR (reprinted with permission from [116]); and (h) FRET biosensor based on GQD-PEG aptamer/MoS2 (reprinted with permission from [23]).